Replies to post #170175 on Innovation Pharmaceuticals Inc (IPIX)

[djs7]

RunningGirl, I hope your right. One mention though is there are quite more exclusion criteria in this trial than the 2A. That being said, they are using a top dermatology CRO this time for the 2B. The original clinical site count needed was 30, but ctix has only required 23/24. Maybe this has meaning toward a fast enrollment. For phase 2A, ctix finished a month ahead of schedule.

Let's hope your right on it being soon.